The key role of interleukin (IL)-23 in the pathogenesis of autoimmune and chronic inflammatory disorders is supported by the identification of IL-23 receptor (IL-23R) susceptibility alleles associated with inflammatory bowel disease, psoriasis and ankylosing spondylitis. IL-23-driven inflammation has primarily been linked to the actions of T-helper type 17 (T H 17) cells 1 . Somewhat overlooked, IL-23 also has inflammatory effects on innate immune cells 2 and can drive T-cell-independent colitis. However, the downstream cellular and molecular pathways involved in this innate intestinal inflammatory response are poorly characterized. Here we show that bacteria-driven innate colitis is associated with an increased production of IL-17 and interferon-c in the colon. Stimulation of colonic leukocytes with IL-23 induced the production of IL-17 and interferon-c exclusively by innate lymphoid cells expressing Thy1, stem cell antigen 1 (SCA-1), retinoic-acid-related orphan receptor (ROR)-ct and IL-23R, and these cells markedly accumulated in the inflamed colon. IL-23-responsive innate intestinal cells are also a feature of T-cell-dependent models of colitis. The transcription factor ROR-ct, which controls IL-23R expression, has a functional role, because Rag 2/2 Rorc 2/2 mice failed to develop innate colitis. Last, depletion of Thy1 1 innate lymphoid cells completely abrogated acute and chronic innate colitis. These results identify a previously unrecognized IL-23-responsive innate lymphoid population that mediates intestinal immune pathology and may therefore represent a target in inflammatory bowel disease.
T H 17 cells produce a variety of inflammatory cytokines, including IL-17, IL-17F, IL-22, IL-6 and tumour necrosis factor (TNF)-a, and are implicated in both host defence against extracellular pathogens and the pathogenesis of several inflammatory disorders 1 . T H 17 cells have recently been shown to have flexibility of function, and acquisition of interferon (IFN)-c production has been linked to their pathogenicity in vivo 3, 4 . Transforming growth factor-b and IL-6 or IL-21 drive T H 17 cell differentiation 5 , and this process is orchestrated by the transcription factor ROR-ct (ref. 6 ). ROR-ct promotes IL-23R expression, permitting IL-23 to control the expansion and maintenance of T H 17 cells 7 . ROR-ct is also expressed by innate lymphoid cells such as intestinal cells that express natural killer (NK) markers, fetal LTi (lymphoid tissue inducer) cells and adult LTi-like cells 8 . Various innate tissue leukocytes, such as CD11c 1 myeloid cells, LTi-like cells and mucosal NKp46 1 cells, have been shown to produce IL-22 and/ or IL-17 on stimulation with IL-23, but the contribution of these tissue-resident innate immune cells to pathology in the intestine is not known 2, [9] [10] [11] .
We have shown that innate immune colitis in Rag 2/2 mice after infection with Helicobacter hepaticus is IL-23 dependent 12 . To identify the cellular and molecular pathways involved, we first analysed the expression of inflammatory cytokines in this model. Consistent with selective upregulation of IL-23 in the intestine 12 of significant increases in the expression of T H 17 and T H 1 signature cytokines, including IL-17, IL-22 and IFN-c, by colonic lamina propria cells (cLP) from H. hepaticus-infected Rag 2/2 mice but not from spleen cells ( Fig. 1a ). IL-23-mediated pathology was not associated with an increase in IL-6 ( Supplementary Fig. 1 ). To determine whether IL-23 acts directly on innate cells to induce T H 1 and T H 17 cytokines, cLP cells were isolated from healthy colons of Rag 2/2 mice and stimulated with IL-12 or IL-23. Addition of IL-23 induced the secretion of IL-17, IL-22 and IFN-c ( Fig. 1b) , whereas IL-12 induced IFN-c only. To determine whether IL-17 and IFN-c have a functional role in innate colitis, H. hepaticus-infected Rag 2/2 mice were treated with neutralizing anti-IL-17 or anti-IFN-c monoclonal antibodies (mAbs). Blockade of either IL-17 or IFN-c was sufficient to decrease colitis significantly ( Fig. 1c, e ) without affecting colonization with H. hepaticus ( Supplementary Fig. 2 ). Similarly, systemic immune activation, assessed by splenomegaly, was also abrogated by IL-17 or IFN-c blockade ( Fig. 1d ). Taken together, these results indicate that H. hepaticus-induced IL-23 regulates the innate expression of effector cytokines such as IL-17 and IFN-c that have functional roles in the intestinal innate inflammatory response.
To identify IL-23-responsive innate immune cells present in the inflamed intestine, we used a cell sorting approach. Using leukocyte lineage (Lin) markers CD11b, GR1 and B220, we found that cytokineexpressing cells were CD45 1 Lin 2 and distinct from common innate cell populations ( Supplementary Fig. 3 ). To identify these cells, we performed intracellular cytokine staining in combination with cellsurface marker expression on IL-23-stimulated cLP cells from colitic mice. We found that IL-23 not only enhanced the frequency of IL-17 1 IFN-c 2 cells but also increased the frequency of IL-17 1 IFN-c 1 cLP cells, whereas the frequency of IL-17 2 IFN-c 1 cells did not increase ( Fig. 2a ). Analysis of surface markers showed that the vast majority of the cLP IL-17-secreting cells expressed high levels of Thy1 ( Fig. 2b ). Lin 2 Thy1 1 cells in Rag 2/2 mice include a population of cells required for the organogenesis of secondary lymphoid organs (SLOs), termed LTi/LTi-like cells 13 . Similarly to classical LTi-like cells, IL-17-expressing cells were found to be IL-7R 1 CD44 1 NKp46 2 CCR6 1 CD25 1 ROR-c 1 (Fig. 2c ). They also expressed LTi-related genes such as those encoding lymphotoxin (LT)-a and LT-b, TNF-related activation-induced cytokine (TRANCE) and CXCR5, recently found to be important for the recruitment of LTi-like cells during inflammation ( Supplementary  Fig. 4 ) (refs 13, 14) . However, IL-17-expressing innate lymphoid cells were also phenotypically distinct from LTi-like cells: they were CD4 2 c-Kit 2 and also expressed SCA-1 (Fig. 2c, d ), suggesting heterogeneity amongst Thy1 1 innate lymphoid cells in the intestine.
To characterize Thy1 high SCA-1 1 innate lymphoid cells further, this population was sorted from the inflamed colon of H. hepaticusinfected Rag 2/2 mice. Even in the absence of cytokine stimulation, the Thy1 high SCA-1 1 population produced IL-17, IL-22 and IFN-c ex vivo, in contrast to most cLP cells (Fig. 2d ). In addition, cytokine secretion was enhanced on stimulation with IL-23 ( Fig. 2d ). Consistent with their production of T H 17 signature cytokines and IFN-c in response to stimulation with IL-23 was our observation that Thy1 high SCA-1 1 cells expressed higher levels of mRNA encoding IL-23R, ROR-ct and Tbx21 but not of mRNA encoding aryl hydrocarbon receptor (AHR) ( Fig. 2e ).
Thy1 high SCA-1 1 innate lymphoid cells were present at low frequency in the Rag 2/2 colon but increased significantly during intestinal inflammation ( Fig. 3a) . Because there is about a tenfold increase in leukocytes in inflamed colons compared with controls 15 , this represents a roughly 100-fold increase in the total number of Thy1 high SCA-1 1 cells. There was also a marked increase in the proportion of Thy1 high SCA-1 1 cells that produced IL-17 de novo from H. hepaticusinfected mice and after IL-23 stimulation, suggesting not only accumulation but also activation of this population in the inflamed intestine (Fig. 3b ). The presence of Thy1 high SCA-1 1 innate lymphoid cells was not restricted to the colon: these cells were also observed in the small intestine ( Supplementary Fig. 5a ). Furthermore, they were present in other tissues in which H. hepaticus has been shown to mediate immune pathology such as the liver 15 , where they also responded to IL-23 by secreting IL-22, IFN-c and IL-17 ( Supplementary Fig. 5b) . A similar population of Lin 2 CD3e 2 Thy1 high cells was also present in the colon of immunocompetent mice both at steady state and during intestinal inflammation induced by infection with H. hepaticus plus concomitant blockade of IL-10R (ref. 16 ) ( Supplementary Fig. 6a ). Lin 2 CD3e 2 Thy1 1 cells again expressed IL-23R, ROR-ct and Tbx21 ( Supplementary Fig. 6b ) and secreted IL-17, IFN-c and IL-22 in response to stimulation with IL-23 ( Supplementary Fig. 6c ). Immunohistological analyses demonstrated that CD3e 2 Thy1 1 cells were localized mainly within leukocytic clusters and were often present in close association with CD3 1 T cell infiltrates ( Supplementary Fig. 7 ). However, some CD3e 2 Thy1 1 cells were also observed scattered throughout the lamina propria ( Supplementary Fig. 7 ).
To determine whether Thy1 high SCA-1 1 innate lymphoid cells had a functional role in H. hepaticus innate immune-driven typhlocolitis, we depleted these cells by injection of an anti-Thy1 mAb during the course of infection ( Supplementary Fig. 8 ). Efficient depletion of Thy1 1 cells led to the abrogation of both colitis and typhlitis (Fig. 3c, e ). IL-23dependent systemic immune activation was also ablated, as shown by the significantly decreased splenomegaly (Fig. 3d ). Absence of intestinal inflammation after depletion of Thy1 1 SCA-1 1 correlated with the abrogation of both the spontaneous and IL-23-induced production of IL-17 and IFN-c by cLP cells (Fig. 3f ).
We next assessed the role of Thy1 high SCA-1 1 cells in another distinct model of IL-23-driven innate intestinal inflammation. Injection of agonistic anti-CD40 mAb into Rag 2/2 mice induces an IL-23dependent acute innate immune colitis that is accompanied by an IL-23-independent systemic inflammatory response 17 . We found that depletion of Thy1 1 cells completely abrogated anti-CD40induced innate colitis (Fig. 4a, b ) but did not affect the IL-23independent systemic wasting disease (Fig. 4c ). In this acute innate colitis model there was no detectable production of IL-17 by Thy1 1 cells from the inflamed colon even after stimulation with IL-23 ( Supplementary Fig. 9a ), and IL-17 was not required for the development of colitis ( Supplementary Fig. 9b, c) . In contrast, intestinal Thy1 high SCA-1 1 cells were found to be the major source of IFN-c during anti-CD40-induced innate colitis, with IL-23 further enhancing their production of IFN-c ( Supplementary Fig. 9d ). Furthermore, depletion of Thy1 1 SCA-1 1 cells was associated with a significant decrease in the production of IFN-c, IL-22 and TNF-a but not that of MCP-1 or IL-6 in the colon (Fig. 4d) . In this innate model, activation of Thy1 high SCA-1 1 by the agonistic anti-CD40 mAb seems to be indirect, because no CD40 expression was observed on these cells ( Supplementary Fig. 10 ).
ROR-ct is required for the development of LTi cells and IL-22producing LTi-like cells 8, 18, 19 . Indeed, we found high expression of ROR-ct by Thy1 high SCA-1 1 compared to the remainder of cells isolated from the colons of mice treated with anti-CD40 (Fig. 4e ). Because ROR-ct is important for IL-23R expression 7 we next assessed whether it was required for the development of anti-CD40-induced innate colitis. Although treatment of Rag 2/2 Rorc 2/2 mice with anti-CD40 mAb elicited potent systemic inflammation and wasting disease comparable to that observed in Rag 2/2 mice (data not shown), Rag 2/2 Rorc 2/2 mice developed only mild intestinal inflammation (Fig. 4f, g) . Attenuated colitis was associated with decreased production of IL-22, IFN-c and TNF-a by cLP cells in Rag 2/2 Rorc 2/2 mice ( Supplementary Fig. 11a ). Although we found no differences between Rag 2/2 and Rag 2/2 Rorc 2/2 mice in the intestinal expression of the IL-23p19 subunit after anti-CD40 treatment, there was a significantly decreased colonic expression of IL-23R in Rag 2/2 Rorc 2/2 mice ( Supplementary Fig. 11b ). Thus, ROR-ct may be important in the control of IL-23R and inflammatory cytokine expression in innate lymphoid cells.
Taken together, our results identify a novel innate lymphoid cell population that accumulates in the inflamed colon and directly mediates IL-23-dependent acute and chronic innate immunemediated colitis through the production of inflammatory cytokines. This innate lymphoid population bears many hallmarks of the colitogenic T-cell response, including the expression of ROR-ct and the production of IL-17 and IFN-c. IL-17 production by innate lymphoid cells was a feature of chronic bacteria-induced colitis but not acute anti-CD40-induced disease, suggesting that the tissue IL-23-driven innate lymphoid response shows flexibility of function and is shaped by environmental factors. The remarkable conservation in function between IL-23-driven ab and cd T-cell responses 20, 21 and IL-23-driven innate lymphoid responses indicates that T H 17-associated effector functions can be generated in the complete absence of TCR-mediated signals. Indeed, the production of IL-17 and IFN-c by innate lymphoid cells may represent a primitive tissue inflammatory response that is activated in response to microbe-induced cytokines such as IL-23 ( Supplementary Fig. 12 ). The tissue innate lymphoid response may extend beyond IL-23-driven responses, because non-B/ non-T Lin 2 and Lin 2 c-Kit 1 SCA-1 1 cells have been shown to be a source of T H 2-type cytokines in response to IL-25 and IL-33, respectively, in parasitic helminth infection models 22, 23 . Intestinal inflammatory innate lymphoid cells share some features of Rorc-dependent LTi cells that mediate lymphoid organogenesis in the fetus as well as those of adult LTi-like cells that produce IL-22 or IL-17 in response to IL-23 or zymosan challenge 2 . Whether these represent distinct tissue innate lymphoid populations or different functional states of the same population is not known. It is notable that hyperplastic lymphoid aggregates have been observed in the colon of patients with inflammatory bowel disease 24, 25 . Furthermore, we have found a similar IL-23-responsive IL-17-producing innate lymphoid cell (ILC) population in the inflamed intestine of patients with inflammatory bowel disease (A. Geremia, C. Arancibia and F.P., unpublished observations).
Intestinal innate lymphoid populations may therefore contribute to chronic intestinal inflammation through effects on organogenesis as well as inflammatory cytokine production. Further characterization of IL-23-responsive ILC in the human intestine is required to establish a role in the pathogenesis of inflammatory bowel disease.
METHODS SUMMARY
Isolation of murine cells. cLP cells were purified as described 26 . In brief, colon tissue was cut into 0.5-cm pieces and incubated in RPMI medium containing 10% heat-inactivated FCS (Gibco-BRL) and 5 mM EDTA to remove epithelial cells. The remaining tissue was further digested with complete RPMI medium containing 15 mM HEPES and 100 U ml 21 collagenase VIII (Sigma Chemical Co.). For liver-cell isolation, livers were perfused at a rate of 2-3 ml min 21 , first with PBS and then with PBS containing 100 U ml 21 of type VIII collagenase. Livers were then cut into small pieces and digested for a further 1 h at 37 uC with complete RPMI medium containing 15 mM HEPES and 100 U ml 21 collagenase VIII. Liver cells and LP cells were then layered on a 30%/40%/75% Percoll gradient (Amersham Pharmacia Biotech). After centrifugation at 600g for 20 min, cells were recovered at the 40%/75% Percoll interface. Cells were stained with a combination of anti-CD45.2, anti-CD11b, anti-Ly6C/G (GR1), anti-B220, anti-CD90.2 (anti-Thy1.2), anti-Ly6A/E (SCA-1) and anti-CD3e antibodies (all from BD Pharmingen) and sorted on a Moflo sorter (DakoCytomation).
Reagents. Cytokine detection in culture supernatants was quantified with a Flow Cytomix Cytokine Bead Assay (Bender MedSystems). Recombinant mouse IL-12 was obtained by transfecting COS7 with the cDNA encoding the p35 and p40 as described previously 27 . Recombinant mouse IL-23 was purchased from R&D. Both recombinant cytokines were used at 10 ng ml 21 for overnight stimulation of cells. Anti-IFN-c and anti-IL-17 antibodies for intracellular staining were obtained from BD Pharmingen, and anti-ROR-c antibody came from eBiosciences. Surface antibodies against CD90.2, CD3e, CD45.2, CD11b, Ly6C/ G, B220, Ly6A/E (SCA-1), CCR6, CD25, CD44, CD117 (c-Kit), CD11c and CD4 were purchased from BD Pharmingen. Antibodies against NKp46 and CD127 (IL-7Ra) were obtained from R&D and eBiosciences, respectively.
